How Biopharma Commercial and R&D Can Partner to Accelerate Digital Innovation
Done right, digital health can make an organization more efficient, more profitable, and better able to serve and delight patients—while gaining a significant competitive edge in a crowded market. But to give digital initiatives more traction in an industry as regulated and complex as healthcare, it requires an all-hands-on-deck, enterprise-wide effort. How can biopharma companies win the race to be digital health leaders?
By aligning commercial and R&D at the outset for digital initiatives, then leveraging this alignment to outpace their competition. Join BrightInsight’s CEO & Co-Founder Kal Patel, MD along with Brent Saunders Chairman, President and Chief Executive Officer of Allergan, and Tobias Silberzahn Partner, McKinsey & Company and Host of the Global Health Tech Network to learn how aligning R&D and commercial in any digital effort can be strategic, patient-centric, efficient – and hugely beneficial. Topics include:
- Best practices for implementing digital initiatives through IT and outside partnerships
- How to champion for digital innovation
- Digitization pitfalls to watch out for
- 5 steps to ensure success of a digital program
Biopharma and R&D